Canada’s Guidance on Cell Therapy Studies Focuses on Risks, Delivery

International Pharmaceutical Regulatory Monitor
A A
Health Canada wants sponsors of cell therapy products to conduct preclinical studies either in vitro or in animals to address potential risks and delivery issues before initiating human trials of the products.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00